Skip to main content
. 2021 Feb 16;104(4):1526–1530. doi: 10.4269/ajtmh.20-1526

Table 2.

Case–control study of demographic and clinical features of patients with SARS-CoV-2–negative and –positive IgG antibodies

SARS-CoV-2 seronegative population (n = 211) SARS-CoV-2 seropositive population (n = 148) Crude OR (95% CI) P-value Adjusted OR (95% CI) P-value
Age (years) 0.9 (1.09–1.0) 0.58 1 (0.9–1.0) 0.87
Gender 0.01 0.08
 Men 119 (56.4%) 63 (42.6%) 0.6 (0.4–0.9) 0.6 (0.4–1.0)
 Women 92 (43.6%) 85 (57.4%) 1 1
Comorbidities 0.63 0.52
 Yes 14 (6.6%) 8 (5.4%) 0.8 (0.3–2.0) 0.7 (0.2–2.0)
 No 197 (93.4%) 140 (94.6%) 1 1
Type of work 0.05* 0.33*
 Administrative staff 19 (9.0%) 17 (11.5%) 1 1
 Cleaning staff and stretcher-bearers 55 (26.1%) 19 (12.8%) 0.4 (0.2–0.9) 0.5 (0.2–1.3)
 Laboratory 6 (2.8%) 6 (4.0%) 1.1 (0.3–4.1) 1.0 (0.2–4.3)
 Paramedical staff 58 (27.5%) 43 (29.0%) 0.8 (0.4–1.8) 0.8 (0.4–1.9)
 Nurse 41 (19.4%) 42 (28.4%) 1.1 (0.5–2.5) 1.2 (0.5–2.8)
 Physician 32 (15.2%) 21 (14.2%) 0.7 (0.3–1.7) 0.7 (0.3–1.8)
Use of personal protective equipment 0.69* 0.59*
 Full 71 (33.6%) 48 (32.4%) 1 1
 Not full 138 (65.4%) 97 (65.5%) 1.0 (0.7–1.6) 1.3 (0.7–2.2)
 No 2 (0.9%) 3 (2.0%) 2.2 (0.3–13.8) 2.0 (0.3–13.8)
Contact with a confirmed case 0.06 0.69
 Yes 106 (50.2%) 89 (60.1%) 1.5 (0.9–2.3) 1.1 (0.7–1.9)
 No 105 (49.8%) 59 (39.9%) 1 1
WHO COVID-19 case definition < 0.001 < 0.001
 Yes 11 (5.2%) 33 (22.3%) 5.2 (2.5–10.7) 5.1 (2.3–11.0)
 No 200 (94.8%) 115 (77.7%) 1 1

OR = odds ratio.

*

P-value by Wald test.

Each OR and P-value are adjusted for all other variables in the (logistic regression).